March 26, 2019
FDA Grants Promedior Breakthrough Therapy Designation for Idiopathic Pulmonary Fibrosis Drug
Read More
May 29, 2017
IPF Patients Treated with Ofev® VS Placebo Were Twice as Likely to Have Improved or Stable Lung Function
Read More
April 1, 2017
Yankees Baseball Legend Bernie Williams Raises Awareness of Devastating Lung Disease – IPF – in Honor of his Dad
Read More
December 7, 2015
New Analyses on OFEV® (nintedanib) Reveals Good News for Idiopathic Pulmonary Fibrosis (IPF) Patients
Read More
December 16, 2014
Patient Support Webinar for Idiopathic Pulmonary Fibrosis Community
Read More
September 17, 2014
New Analysis of Boehringer Ingelheim’s IPF Therapy Nintedanib on Lung Function Decline
Read More
July 2, 2014
Boehringer Ingelheim Announces Nintedanib Expanded Access Program (EAP) for Patients with Idiopathic Pulmonary Fibrosis
Read More
June 11, 2014
Registry for Fatal Lung Disease Aims to Speed Improvements in Care
Read More
May 8, 2013
The Balancing Act’s “Behind the Mystery: Rare and Genetic Diseases” to Feature Idiopathic Pulmonary Fibrosis May 9th/16th
Read More
April 26, 2013
My Sweet Dad Diagnosed with Pulmonary Fibrosis
Read More
October 5, 2012
Health Canada Approves Esbriet® as First Treatment for Fatal Lung Disease
Read More
X